By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk's shares tumbled on Wednesday, ...
Novo Nordisk share price plunges after blaming lower US drug prices, patent protection issues and rising competition ...
Novo Nordisk and Eli Lilly both think the Wegovy pill is doing well, but the American rival sees the successful launch as a harbinger of good news for its own candidate, orforglipron, which is ...
Publix Pharmacy is offering a discount card program for select GLP-1 medications like Wegovy and Ozempic. Here are the ...
Wegovy pills are now available in the U.S., offering a prescription-based, convenient alternative for weight management ...
Novo Nordisk CEO Maziar Mike Doustdar acknowledged the market pressure facing the company’s GLP-1 products but sought to ...
Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.
The American maker of Mounjaro has struck a decisive blow against its European rival behind Ozempic and Wegovy as the battle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results